Neural differentiation of human Wharton's jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke rats
Human Wharton's jelly-derived mesenchymal stem cells (hWJ-MSCs) have excellent proliferative ability, differentiation ability, low immunogenicity, and can be easily obtained. However, there are few studies on their application in the treatment of ischemic stroke, therefore their therapeutic eff...
Main Authors: | Lei Zhang, Lin-mei Wang, Wei-wei Chen, Zhi Ma, Xiao Han, Cheng-ming Liu, Xiang Cheng, Wei Shi, Jing-jing Guo, Jian-bing Qin, Xiao-qing Yang, Guo-hua Jin, Xin-hua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=7;spage=1103;epage=1110;aulast=Zhang |
Similar Items
-
Differentiation of Wharton′s jelly mesenchymal stem cells into neurons in alginate scaffold
by: Seyed Mojtaba Hosseini, et al.
Published: (2015-01-01) -
Administration of Human Umbilical Cord Whartons Jelly-Derived Mesenchymal Stem Cells on Rat Sciatic Nerve Regeneration
by: S Ebrahimi Vosta Kalaee, et al.
Published: (2013-03-01) -
Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
by: Raquel Cabrera-Pérez, et al.
Published: (2019-11-01) -
Evaluating the Differential Effects of Valproic Acid on Wharton’s Jelly Mesenchymal Stem Cells
by: Homa Salami, et al.
Published: (2019-08-01) -
Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury
by: Kuo-Jen Wu, et al.
Published: (2018-01-01)